Insights on Clinical Trials

  1. Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer 11/17/2025

    Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

  2. Early Phase Oncology Site Network: Benefits Of A Personal Touch 11/17/2025

    Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.

  3. The Growing Complexity Of Conducting Oncology Trials 11/17/2025

    As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.

  4. Investor Relations, Clinical Operations, And The Future Of Biotech Financing 11/17/2025

    Discover how integrating clinical execution with investor strategy can strengthen your position in a tougher capital landscape and accelerate your path to market.

  5. Lost In Translation: Turning Multi-Omic Chaos Into Clinical Clarity 11/17/2025

    Uncover how this integrated, science-focused approach helps sponsors navigate biological complexity, streamline timelines, and make data-driven decisions across a collection of therapy programs.

  6. Quantitative ROI With DCTs 11/13/2025

    Through dedicated staffing, operational oversight, and collaboration with site teams, see how we were able to transform a struggling cardiology study into a revitalized recruitment effort.

  7. The True ROI Of Decentralized Clinical Trials 11/13/2025

    Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

  8. How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology? 11/7/2025

    By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.

  9. Addressing A Global Health Priority In Australia And New Zealand 11/7/2025

    For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.

  10. Highlights From The 2025 International Hepatitis B Meeting 11/7/2025

    For biotech and pharmaceutical teams, the core message was clear: progress is accelerating, but success still depends on smart study design, fit-for-purpose endpoints, and operational execution.